Shield Therapeutics SHIEF Stock
Shield Therapeutics Price Chart
Shield Therapeutics SHIEF Financial and Trading Overview
| Shield Therapeutics stock price | 0.02 USD |
| Previous Close | 0.09 USD |
| Open | 0.09 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.09 - 0.09 USD |
| 52 Week Range | 0.07 - 0.2 USD |
| Volume | 6.26K USD |
| Avg. Volume | 281 USD |
| Market Cap | 64.17M USD |
| Beta (5Y Monthly) | 0.995019 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.15 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SHIEF Valuation Measures
| Enterprise Value | 26.15M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 14.366072 |
| Price/Book (mrq) | 4.2857146 |
| Enterprise Value/Revenue | 5.855 |
| Enterprise Value/EBITDA | -1.086 |
Trading Information
Shield Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.995019 |
| 52-Week Change | -55.0000000000000071% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.2 USD |
| 52 Week Low | 0.07 USD |
| 50-Day Moving Average | 0.09 USD |
| 200-Day Moving Average | 0.1 USD |
SHIEF Share Statistics
| Avg. Volume (3 month) | 281 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 713.04M |
| Float | 124.37M |
| Short Ratio | N/A |
| % Held by Insiders | 47.53% |
| % Held by Institutions | 14.32% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -575.46% |
| Gross Margin | 44.70% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -48.33% |
| Return on Equity (ttm) | -175.39% |
Income Statement
| Revenue (ttm) | 4.47M USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | 134.69% |
| Gross Profit (ttm) | 2M USD |
| EBITDA | -24076000 USD |
| Net Income Avi to Common (ttm) | -40444000 USD |
| Diluted EPS (ttm) | -0.21 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.82M USD |
| Total Cash Per Share (mrq) | 0.01 USD |
| Total Debt (mrq) | 5.63M USD |
| Total Debt/Equity (mrq) | 103.76 USD |
| Current Ratio (mrq) | 0.949 |
| Book Value Per Share (mrq) | 0.021 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17312000 USD |
| Levered Free Cash Flow (ttm) | -10208625 USD |
Profile of Shield Therapeutics
| Country | United States |
| State | N/A |
| City | Gateshead |
| Address | Northern Design Centre |
| ZIP | NE8 3DF |
| Phone | 44 1915 118 500 |
| Website | https://www.shieldtherapeutics.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 27 |
Shield Therapeutics plc, a specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.
Q&A For Shield Therapeutics Stock
What is a current SHIEF stock price?
Shield Therapeutics SHIEF stock price today per share is 0.02 USD.
How to purchase Shield Therapeutics stock?
You can buy SHIEF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shield Therapeutics?
The stock symbol or ticker of Shield Therapeutics is SHIEF.
Which industry does the Shield Therapeutics company belong to?
The Shield Therapeutics industry is Drug Manufacturers-Specialty & Generic.
How many shares does Shield Therapeutics have in circulation?
The max supply of Shield Therapeutics shares is 782.06M.
What is Shield Therapeutics Price to Earnings Ratio (PE Ratio)?
Shield Therapeutics PE Ratio is now.
What was Shield Therapeutics earnings per share over the trailing 12 months (TTM)?
Shield Therapeutics EPS is -0.15 USD over the trailing 12 months.
Which sector does the Shield Therapeutics company belong to?
The Shield Therapeutics sector is Healthcare.